NanoRepro AG (XETRA: NN6) Stock Analysis & Fundamentals | ScreenerHero

Create free account

NN6NanoRepro AG

XETRA · DE · Healthcare · Diagnostics & Research · nanorepro.com

1.980EUR-4.81%Mkt Cap: 27.15M $P/E: —1d ago

NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the are…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Cheaper

1M Perf

Avg

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap27.15M $

Enterprise Value19.22M $

Revenue (TTM)5.61M $

Gross Profit3.20M $

Net Income (TTM)-2.22M $

Revenue/Share0.4457 USD

Last Price1.980 EUR

Fiscal Year EndDec 2024

MR QuarterJun 2025

Employees20

CountryDE

SectorHealthcare

IndustryDiagnostics & Research

ISINDE0006577109

Valuation

P/E (Trailing)—

P/E (Forward)-49.50

PEG—

EV/EBITDA-7.80

EV/Revenue3.42

P/S4.83

P/B0.67

EPS (TTM)-0.14

EPS (Forward)-0.04

52W Range

1.31078% of range2.170

52W High2.170 EUR

52W Low1.310 EUR

Profitability

Gross Margin63.38%

Oper. Margin-38.37%

EBITDA Margin-43.91%

Profit Margin-44.02%

ROE-5.36%

ROA-5.24%

Growth

Revenue Growth37.00%

Earnings Growth—

Cash Flow & Leverage

Operating CF10.72M $

CapEx (TTM)437.61K $

FCF Margin—

FCF Yield—

Net Debt-7.92M $

Net Debt/EBITDA3.21

Balance Sheet

Debt/Equity—

Current Ratio31.90

Quick Ratio24.56

Book Value/Sh2.957 EUR

Cash/Share0.5780 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 EUR

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div DateJun 16, 2023

Pay Date—

Analyst Consensus

Rating1.0 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)4.400 EUR

Upside (mean)+122.2%

Target Range4.300 EUR – 4.500 EUR

€4.300+122.2% to mean€4.500

# Analysts2

Ownership

Shares Out.12.61M

Float—

Insiders2.00%

Institutions10.05%

Technical

SMA 501.713 (+15.6%)

SMA 2001.595 (+24.1%)

Beta0.53

S&P 52W Chg20.05%

Avg Vol (30d)19.39K

Avg Vol (10d)23.52K

Technical Indicators

RSI (14)61.6

MACD0.1044

MACD Signal0.0995

MACD Hist.+0.0049

BB Upper2.165 EUR

BB Middle1.903 EUR

BB Lower1.641 EUR

BB Width27.58%

ATR (14)0.0961 EUR

Vol Ratio (20d)0.38x